[HTML][HTML] Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
The spread of the Omicron SARS-CoV-2 variant underscores the importance of analyzing
the cross-protection from previous non-Omicron infection. We have developed a high …
the cross-protection from previous non-Omicron infection. We have developed a high …
[HTML][HTML] SARS-CoV-2 Omicron strain exhibits potent capabilities for immune evasion and viral entrance
X Zhang, S Wu, B Wu, Q Yang, A Chen, Y Li… - Signal transduction and …, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron strain (as known
as B. 1.1. 529) was identified in Botswana and South Africa in early November 2021 and …
as B. 1.1. 529) was identified in Botswana and South Africa in early November 2021 and …
[HTML][HTML] SARS-CoV-2 Omicron neutralization by therapeutic antibodies, convalescent sera, and post-mRNA vaccine booster
The rapid spread of the highly contagious Omicron variant of SARS-CoV-2 along with its
high number of mutations in the spike gene has raised alarm about the effectiveness of …
high number of mutations in the spike gene has raised alarm about the effectiveness of …
[HTML][HTML] SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection
The emergence of SARS-CoV-2 Omicron, first identified in Botswana and South Africa, may
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
compromise vaccine effectiveness and the ability of antibodies triggered by previous …
[HTML][HTML] Booster of mRNA-1273 strengthens SARS-CoV-2 Omicron neutralization
NA Doria-Rose, X Shen, SD Schmidt, S O'Dell… - MedRxiv, 2021 - ncbi.nlm.nih.gov
The Omicron variant of SARS-CoV-2 is raising concerns because of its increased
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess …
transmissibility and potential for reduced susceptibility to antibody neutralization. To assess …
[HTML][HTML] Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination
Abstract SARS-CoV-2 Delta and Omicron are globally relevant variants of concern. Although
individuals infected with Delta are at risk of developing severe lung disease, infection with …
individuals infected with Delta are at risk of developing severe lung disease, infection with …
[PDF][PDF] SARS-CoV-2 Omicron triggers cross-reactive neutralization and Fc effector functions in previously vaccinated, but not unvaccinated, individuals
SI Richardson, VS Madzorera, H Spencer… - Cell Host & Microbe, 2022 - cell.com
Summary The SARS-CoV-2 Omicron variant escapes neutralizing antibodies elicited by
vaccines or infection. However, whether Omicron triggers cross-reactive humoral responses …
vaccines or infection. However, whether Omicron triggers cross-reactive humoral responses …
[HTML][HTML] Human serum from SARS-CoV-2-vaccinated and COVID-19 patients shows reduced binding to the RBD of SARS-CoV-2 Omicron variant
Background The COVID-19 pandemic is caused by the betacoronavirus SARS-CoV-2. In
November 2021, the Omicron variant was discovered and immediately classified as a …
November 2021, the Omicron variant was discovered and immediately classified as a …
[HTML][HTML] Attenuated replication and pathogenicity of SARS-CoV-2 B. 1.1. 529 Omicron
Abstract The Omicron (B. 1.1. 529) variant of SARS-CoV-2 emerged in November 2021 and
is rapidly spreading among the human population. Although recent reports reveal that the …
is rapidly spreading among the human population. Although recent reports reveal that the …
[PDF][PDF] mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) omicron variant
emerged in November 2021 and consists of several mutations within the spike. We use …
emerged in November 2021 and consists of several mutations within the spike. We use …